← Back to Search

Virus Therapy

Treatment arm for Color Blindness (Colourbridge Trial)

Phase 1 & 2
Waitlist Available
Led By Dominik Fischer, Prof.
Research Sponsored by STZ eyetrial
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 14 - day 365
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to proof the safety and efficacy of a single bilateral subretinal injection of rAAV.hCNGA3 in adult and minor patients with CNGA3-linked achromatopsia.

Eligible Conditions
  • Color Blindness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 14 - day 365
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 14 - day 365 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Safety (AE). Number of Participants With Abnormal Laboratory Values and/or Adverse Events That Are Related to Treatment
Secondary study objectives
Efficacy measures. Number of Participants With improved Visual Function.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Waiting group ArmExperimental Treatment1 Intervention
Waiting group will serve as comparator group first and will receive the treatment at a later timepoint.
Group II: Treatment armExperimental Treatment1 Intervention
single subretinal injection of 1x10e11 vector genome particles of rAAV.hCNGA3 in each eye at different time-points

Find a Location

Who is running the clinical trial?

STZ eyetrialLead Sponsor
4 Previous Clinical Trials
109 Total Patients Enrolled
University Hospital TuebingenOTHER
572 Previous Clinical Trials
336,522 Total Patients Enrolled
Ludwig-Maximilians - University of MunichOTHER
359 Previous Clinical Trials
209,008 Total Patients Enrolled
~3 spots leftby Jun 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top